202 related articles for article (PubMed ID: 3780634)
21. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
22. The influence of a hyperthermia treatment on chemically induced tumor initiation and progression in mouse skin.
Mitchel RE; Morrison DP; Gragtmans NJ
Carcinogenesis; 1988 Mar; 9(3):379-85. PubMed ID: 3125992
[TBL] [Abstract][Full Text] [Related]
23. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
[TBL] [Abstract][Full Text] [Related]
24. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis.
Miller DR; Viaje A; Rotstein J; Aldaz CM; Conti CJ; Slaga TJ
Cancer Res; 1989 Jan; 49(2):410-4. PubMed ID: 2491955
[TBL] [Abstract][Full Text] [Related]
25. Hyperthermia and phorbol ester tumor promotion in mouse skin.
Mitchel RE; Morrison DP; Gragtmans NJ; Jevcak JJ
Carcinogenesis; 1986 Sep; 7(9):1505-10. PubMed ID: 3091284
[TBL] [Abstract][Full Text] [Related]
26. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin.
Niwa Y; Terashima T; Sumi H
Br J Dermatol; 2003 Nov; 149(5):960-7. PubMed ID: 14632799
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the tumorigenic response of SENCAR and C57BL/6 mice to benzo(a)pyrene and the inter-experimental variability over a three-year period.
Nesnow S; Bergman H; Slaga TJ
Environ Health Perspect; 1986 Sep; 68():19-25. PubMed ID: 3780628
[TBL] [Abstract][Full Text] [Related]
28. All-trans retinoic acid protects against conversion of chemically induced and ultraviolet B radiation-induced skin papillomas to carcinomas.
Athar M; Agarwal R; Wang ZY; Lloyd JR; Bickers DR; Mukhtar H
Carcinogenesis; 1991 Dec; 12(12):2325-9. PubMed ID: 1747935
[TBL] [Abstract][Full Text] [Related]
29. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
Kruszewski FH; Conti CJ; DiGiovanni J
Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
[TBL] [Abstract][Full Text] [Related]
30. High dietary retinoic acid inhibits tumor promotion and malignant conversion in a two-stage skin carcinogenesis protocol using 7,12-dimethylbenz[a]anthracene as the initiator and mezerein as the tumor promoter in female SENCAR mice.
Chen LC; Tarone R; Huynh M; De Luca LM
Cancer Lett; 1995 Aug; 95(1-2):113-8. PubMed ID: 7656218
[TBL] [Abstract][Full Text] [Related]
31. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the antioxidant/prooxidant status of murine skin following topical treatment with 12-O-tetradecanoylphorbol-13-acetate and throughout the ontogeny of skin cancer. Part II: Quantitation of glutathione and glutathione disulfide.
Reiners JJ; Kodari E; Cappel RE; Gilbert HF
Carcinogenesis; 1991 Dec; 12(12):2345-52. PubMed ID: 1747938
[TBL] [Abstract][Full Text] [Related]
33. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
34. Association of carcinoma yield with early papilloma development in SENCAR mice.
Bull RJ; Robinson M; Laurie RD
Environ Health Perspect; 1986 Sep; 68():11-7. PubMed ID: 3780623
[TBL] [Abstract][Full Text] [Related]
35. Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters.
Hennings H; Shores R; Wenk ML; Spangler EF; Tarone R; Yuspa SH
Nature; 1983 Jul 7-13; 304(5921):67-9. PubMed ID: 6866091
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
37. Malignant conversion of UV radiation and chemically induced mouse skin benign tumors by free-radical-generating compounds.
Athar M; Lloyd JR; Bickers DR; Mukhtar H
Carcinogenesis; 1989 Oct; 10(10):1841-5. PubMed ID: 2507187
[TBL] [Abstract][Full Text] [Related]
38. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
Ewing MW; Crysup SE; Phillips JL; Slaga TJ; DiGiovanni J
Carcinogenesis; 1988 Mar; 9(3):405-10. PubMed ID: 3125993
[TBL] [Abstract][Full Text] [Related]
40. Consumption of reduced-energy/low-fat diet or constant-energy/high-fat diet during mezerein treatment inhibited mouse skin tumor promotion.
Birt DF; Pelling JC; Anderson J; Barnett T
Carcinogenesis; 1994 Oct; 15(10):2341-5. PubMed ID: 7955075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
